: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Explore this week’s CC Journal Club

90‑sec video • 4‑min audio • paper abstracts

Bladder Cancer, March 2025
Free Subscription

Abstracts
Retrieve all available abstracts of the following 314 articles:
HTML format

Single Articles

CHEN L, Hao Y, Zhai T, Yang F, et al
Single-cell Analysis Highlights Anti-apoptotic Subpopulation Promoting Malignant Progression and Predicting Prognosis in Bladder Cancer.
Cancer Inform. 2025;24:11769351251323569.
PubMed
Abstract available

CHEN SY, Zhang YL, Li XR, Wang JR, et al
BIN1 inhibited tumor growth, metastasis and stemness by ALDH1/NOTCH pathway in bladder carcinoma.
Hereditas. 2025;162:29.
PubMed
Abstract available

HU B, Zhao T, Li Y, Li K, et al
Identification of E3 ubiquitin ligase-based molecular subtypes and prognostic signature regarding prognosis and immune landscape in bladder cancer.
Cancer Cell Int. 2025;25:70.
PubMed
Abstract available

LI J, Yang B, Guo L, Huang W, et al
SFRP2 mediates Epstein-Barr virus and bladder cancer risk: a Mendelian randomization study and colocalization analysis.
Sci Rep. 2025;15:7118.
PubMed
Abstract available

ZHANG Z, Liu X, Tian F, Wang Y, et al
Aspartate Isomerization Regulates in Situ Assembly of Peptides into Supramolecular Probes for Detection of Protein Carboxyl Methyltransferase in Bladder Cancer.
Nano Lett. 2025 Feb 27. doi: 10.1021/acs.nanolett.4c06452.
PubMed
Abstract available

YU J, Yao P, Yang X, Xiong L, et al
Association of pickled food consumption with non-digestive system cancers: a systematic review and meta-analysis.
BMJ Open. 2025;15:e082786.
PubMed
Abstract available

BAHLBURG H, Noldus J, Roghmann F
[Intravesical treatment of non-muscle-invasive bladder cancer].
Urologie. 2025 Feb 27. doi: 10.1007/s00120-025-02522.
PubMed
Abstract available

TAKEMOTO K, Kobatake K, Hatayama T, Tasaka S, et al
DGKalpha Enhances Tumorigenic Activity in Bladder Cancer Patients With Chronic Kidney Disease.
Cancer Med. 2025;14:e70710.
PubMed
Abstract available

LIANG W, Wang Z, Huang Z, Huang Y, et al
Effectiveness and safety of PD-1/L1 inhibitors as first-line therapy for patients with advanced or metastatic urothelial carcinoma who are ineligible for platinum-based chemotherapy: a meta-analysis.
Front Immunol. 2025;16:1430673.
PubMed
Abstract available

WANG X, You H, Zhang T, Li Y, et al
Immunoproteasome subunits are novel signatures for predicting efficacy of immunotherapy in muscle invasive bladder cancer.
J Transl Med. 2025;23:228.
PubMed
Abstract available

A R, Ueki H, Nishioka S, Yamazaki R, et al
A conditionally replicative adenovirus vector containing the synNotch receptor gene for the treatment of muscle-invasive bladder cancer.
Cancer Gene Ther. 2025 Feb 26. doi: 10.1038/s41417-025-00879.
PubMed
Abstract available

WANG WD, Yang XR, Li WH, Cheng JM, et al
Analysis the diagnostic performance of H4C6/SOX1-OT gene methylation in bladder cancer based on urine sample.
Sci Rep. 2025;15:6961.
PubMed
Abstract available

WANG WS, Liu YC, Lo TL, Hsu FT, et al
Imipramine-induced Apoptosis and Metastasis Inhibition in Human Bladder Cancer T24 Cells Through EGFR/ERK/NF-kappaB Pathway Suppression.
In Vivo. 2025;39:669-682.
PubMed
Abstract available

BLANCA A, Lopez-Beltran A, Gomez-Gomez E, Campos-Hernandez P, et al
Prognostic significance of PD-1, PD-L1, PD-L2 and FGFR3 mRNA expression in bladder cancer.
Pathobiology. 2025 Feb 26:1-19. doi: 10.1159/000544733.
PubMed
Abstract available

HORKOSS G, Khoury JE, Halabi R, Kanbar A, et al
Factors influencing smoking cessation in Lebanese patients with bladder cancer: A cross sectional study.
Cancer Treat Res Commun. 2025;43:100879.
PubMed
Abstract available

ALTWAIRGI A
CHRONIC INFECTION WITH SCHISTOSOMA HAEMATOBIUM LEADS TO THE DEVELOPMENT OF SQUAMOUS CELL CARCINOMA OF THE BLADDER.
Georgian Med News. 2024;:99-103.
PubMed
Abstract available

LI D, Wang Z, Yu Q, Wang J, et al
Tracing the Evolution of Sex Hormones and Receptor-Mediated Immune Microenvironmental Differences in Prostate and Bladder Cancers: From Embryonic Development to Disease.
Adv Sci (Weinh). 2025 Feb 25:e2407715. doi: 10.1002/advs.202407715.
PubMed
Abstract available

LIU CW, Chen PH, Lin KJ, Cheng YT, et al
Novel Hydrogel-Mediated Lentiviral Gene Delivery via Intravesical Administration for Bladder Cancer Treatment.
Pharmaceutics. 2025;17:143.
PubMed
Abstract available

NALKIRAN I, Sevim Nalkiran H
Phytochemical Profile and Anticancer Potential of Helichrysum arenarium Extracts on Glioblastoma, Bladder Cancer, and Breast Cancer Cells.
Pharmaceuticals (Basel). 2025;18:144.
PubMed
Abstract available

FRANKOVIC L, Degoricija M, Gabela I, Vilovic K, et al
Pro-Tumorigenic Effect of Continuous Cromolyn Treatment in Bladder Cancer.
Int J Mol Sci. 2025;26:1619.
PubMed
Abstract available

BITINA-BARLOTE E, Bliznuks D, Silina S, Satcs M, et al
Liquid Biopsy Based Bladder Cancer Diagnostic by Machine Learning.
Diagnostics (Basel). 2025;15:492.
PubMed
Abstract available

LANGE A, Madiraju S, Petros FG
Therapeutic Advances in Bladder Preservation for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer.
Cancers (Basel). 2025;17:636.
PubMed
Abstract available

BOLA B, Hoskin PJ, Sangar V, Choudhury A, et al
The Promise of Radiotherapy in High-Risk Non-Muscle Invasive Bladder Cancer.
Cancers (Basel). 2025;17:628.
PubMed
Abstract available

BRAUN A, Deng M, Hasler JS, Bukavina L, et al
Association between antibiotics and treatment efficacy in metastatic urothelial carcinoma patients.
BMC Med. 2025;23:117.
PubMed
Abstract available

ZHAO Q, Liu MY, Gao KX, Zhang BS, et al
Predicting 90-day risk of urinary tract infections following urostomy in bladder cancer patients using machine learning and explainability.
Sci Rep. 2025;15:6807.
PubMed
Abstract available

RETRACTION: Comparing Surgical Site Wound Infection After Laparoscopic and Open Radical Cystectomies in Patients with Bladder Cancer.
Int Wound J. 2025;22:e70263.
PubMed
Abstract available

DAI WC, Chen TH, Peng TC, He YC, et al
Blockade of the STAT3/BCL-xL Axis Leads to the Cytotoxic and Cisplatin-Sensitizing Effects of Fucoxanthin, a Marine-Derived Carotenoid, on Human Bladder Urothelial Carcinoma Cells.
Mar Drugs. 2025;23:54.
PubMed
Abstract available

SINGH SP, Pathuri G, Asch AS, Rao CV, et al
Correction: Singh et al. Stat3 Inhibitors TTI-101 and SH5-07 Suppress Bladder Cancer Cell Survival in 3D Tumor Models. Cells 2024, 13, 1463.
Cells. 2025;14:299.
PubMed
Abstract available

ZHOU Z, Zhang Y, Zhou Y, Gu J, et al
Construction and verification of a prognostic model for bladder cancer based on disulfidptosis-related angiogenesis genes.
PeerJ. 2025;13:e18911.
PubMed
Abstract available

TADESSE DA, Rothman N, Xie S, Hurwitz LM, et al
Solvent exposure, genetic susceptibility, and risk of bladder cancer.
Cancer Prev Res (Phila). 2025 Feb 25. doi: 10.1158/1940-6207.CAPR-24-0434.
PubMed
Abstract available

LIU P, Cai L, Jiang L, Chen H, et al
Comparative diagnostic performance of VI-RADS based on biparametric and multiparametric MRI in predicting muscle invasion in bladder cancer.
BMC Med Imaging. 2025;25:60.
PubMed
Abstract available

CHIN FW, Chan SC, Chau DM, Ong TA, et al
HOXA13 promotes immune evasion in bladder cancer by suppressing antigen processing and presentation, and phagosome pathways.
Funct Integr Genomics. 2025;25:44.
PubMed
Abstract available

SIGHINOLFI MC, Panio E, Calcagnile T, Assumma S, et al
Radical Cystectomy with Elective Indication to Cutaneous Ureterostomy: Single-Center Comparative Analysis Between Open and Robotic Surgery in Frail Patients.
Int Braz J Urol. 2025;51:e20240556.
PubMed
Abstract available

TAN Z, Chen X, Huang Y, Fu S, et al
Integrative multi-omics and machine learning identify a robust signature for discriminating prognosis and therapeutic targets in bladder cancer.
J Cancer. 2025;16:1479-1503.
PubMed
Abstract available

LI D, Su H, Deng X, Huang Y, et al
DARS2 Promotes Bladder Cancer Progression by Enhancing PINK1-Mediated Mitophagy.
Int J Biol Sci. 2025;21:1530-1544.
PubMed
Abstract available

MANICKAVASAGAR U, Nel H, Seet J, Varrone L, et al
Mycobacterium bovis Infections Following Intravesical Bacillus Calmette-Guerin Instillation for Bladder Cancer in Western Australia: A 22-Year Retrospective Review.
Open Forum Infect Dis. 2025;12:ofaf070.
PubMed
Abstract available

DENG Z, Zhou F, Li M, Jin W, et al
DLGAP5 enhances bladder cancer chemoresistance by regulating glycolysis through MYC stabilization.
Theranostics. 2025;15:2375-2392.
PubMed
Abstract available

EL AHANIDI H, El Azzouzi M, Addoum B, Tetou M, et al
STAT1 and STAT4 expression as prognostic biomarkers in patients with bladder cancer.
Mol Clin Oncol. 2025;22:33.
PubMed
Abstract available

ZHAO Y, Shi G, Huang X, Zhang Z, et al
LRP8 inhibits bladder cancer cell ferroptosis by activating the Wnt/beta-catenin-SCD1 positive feedback loop.
Hum Mol Genet. 2025 Feb 24:ddaf024. doi: 10.1093.
PubMed
Abstract available

LU Y, Wang J, Bi X, Qian H, et al
Non-invasive and rapid diagnosis of low-grade bladder cancer via SERSomes of urine.
Nanoscale. 2025 Feb 24. doi: 10.1039/d4nr05306.
PubMed
Abstract available

FONG KY, Lim EJ, Wong HC, Tay KJ, et al
Trimodality therapy versus radical cystectomy for muscle-invasive bladder cancer: A systematic review and meta-analysis.
Urol Oncol. 2025 Feb 21:S1078-1439(25)00011.
PubMed
Abstract available

BEDORE S, Aguilar K, Lokeshwar VB
Natural history of bladder cancer: Validation of the multiple pathway model in multi-omics era.
Urol Oncol. 2025;43:88-93.
PubMed
Abstract available

SCHMITZ-DRAGER BJ, Grossmann HB, Goebell PJ, Kamat AM, et al
Change of the guards-Looking back at Michael Droller: Visionary and supporter-The perspective of the International Bladder Cancer Network.
Urol Oncol. 2025;43:129-131.
PubMed
Abstract available

LAWRENCE SS, Yamashita H, Shuman L, Raman JD, et al
Interferon-gamma/Janus kinase 1/STAT1 Signaling Represses Forkhead Box A1 and Drives a Basal Transcriptional State in Muscle-Invasive Bladder Cancer.
Am J Pathol. 2025 Feb 20:S0002-9440(25)00068.
PubMed
Abstract available

HRECHKO B, Voylenko O, Pikul M, Vitruk U, et al
Cystectomy in Metastatic Bladder Cancer: Feasibility, Safety and Outcomes.
Exp Oncol. 2025;46:345-250.
PubMed
Abstract available

YAKOVLEV P, Kuts V, Zemskov S, Vereshchako R, et al
Quality of Life Assessed by the Questionnaire MOS SF-36 in Bladder Cancer Patients Depending on the Method of Surgical Treatment.
Exp Oncol. 2025;46:351-357.
PubMed
Abstract available

HARIRI D, Pavlick D, Spiess P, Li R, et al
Primary sarcomas of the bladder and prostate: A genomic landscape study.
Pathol Res Pract. 2025;267:155840.
PubMed
Abstract available

SIBAI M, Cervilla S, Grases D, Musulen E, et al
The spatial landscape of cancer hallmarks reveals patterns of tumor ecological dynamics and drug sensitivity.
Cell Rep. 2025;44:115229.
PubMed
Abstract available

SIDDHARTHA R, Singhai A, Goel A, Garg M, et al
CD105-microvessel density analysis and its clinical value in urothelial carcinoma of bladder patients.
Biomarkers. 2025;30:23-36.
PubMed
Abstract available

DORENBERG J, Schmidt CJ, Berlage T, Knuchel-Clarke R, et al
[Establishment of a German ICCR dataset : Translation and integration of SNOMED CT using the example of TUR-B].
Pathologie (Heidelb). 2025;46:108-114.
PubMed
Abstract available

ALGHAFEES M, Chakra MA, Alkhayal A, Moussa M, et al
Saudi urologists' treatment pattern for high-risk Bacillus Calmette-Guerin naive and Bacillus Calmette-Guerin unresponsive nonmuscle invasive bladder cancer.
Urol Ann. 2025;17:58-63.
PubMed
Abstract available

WANG S, Zheng B, Yang J, Zhang J, et al
Competing Risk Analysis for Diabetes Mellitus Mortality in Bladder Cancer Patients: A Population-based Study.
Curr Cancer Drug Targets. 2025 Mar 7. doi: 10.2174/0115680096356675250217074915.
PubMed
Abstract available

RADU CG, Calinoiu PC, Radavoi GD, Aurelian J, et al
Comparison of Perioperative and Postoperative Outcomes in Patients with Urinary Diversions: Direct Cutaneous Ureterostomy versus Bricker Ileal Conduit Technique Following Radical Cystectomy.
Chirurgia (Bucur). 2025;120:103-116.
PubMed
Abstract available

TANAKA Y, Takeshita H, Yokota K, Chon S, et al
Two Cases of Revisional Urinary Diversion from Ureterocutaneostomy to Ileal Conduit: A Staged Urinary Diversion Strategy for Patients with Bladder Cancer in the Targeted and Immunotherapy Era.
Am J Case Rep. 2025;26:e946924.
PubMed
Abstract available

CHEN J, Kudinova N, Dubrovsky R, Thomas J, et al
Selectivity and anti-tumor immune elevation by vascular-targeted photodynamic therapy of mouse orthotopic bladder cancer model.
Photochem Photobiol. 2025 Mar 6. doi: 10.1111/php.14048.
PubMed
Abstract available

STEINER L, Eldh M, Offens A, Veerman RE, et al
Corrigendum to "Protein profile in urinary extracellular vesicles is a marker of malignancy and correlates with muscle invasiveness in urinary bladder cancer" [Cancer Lett. 609 (2025) 217352].
Cancer Lett. 2025 Mar 5:217592. doi: 10.1016/j.canlet.2025.217592.
PubMed

HATAYAMA T, Mita K, Kohada Y, Fujiyama K, et al
Efficacy of scheduled intravenous acetaminophen administration for catheter-related bladder discomfort in patients after transurethral resection of bladder tumors: A prospective randomized pilot study.
Investig Clin Urol. 2025;66:144-151.
PubMed
Abstract available

KOSSENAS K, Kouzeiha RA, Moutzouri O, Georgopoulos F, et al
Intracorporeal Versus Extracorporeal Urinary Diversion Following Robotic-Assisted Radical Cystectomy for Bladder Cancer in Patients >/= 65 Years of Age: A Systematic Review and Meta-Analysis.
Cureus. 2025;17:e78406.
PubMed
Abstract available

YU J, Chen L, Wang G, Qian K, et al
RBPMS inhibits bladder cancer metastasis by downregulating MYC pathway through alternative splicing of ANKRD10.
Commun Biol. 2025;8:367.
PubMed
Abstract available

NICOLAZZINI M, Rodriguez Penaranda N, Falkenbach F, Longoni M, et al
The effect of chronic kidney disease on adverse in-hospital outcomes after radical cystectomy with ileal conduit urinary diversion.
World J Urol. 2025;43:149.
PubMed
Abstract available

KLEIN MN, Adesanya O, Xu VE, Gordon O, et al
Analysis of Neoadjuvant Immunotherapy and Chemotherapy for Muscle-Invasive Bladder Cancer in a National Registry.
Clin Genitourin Cancer. 2025 Feb 10:102316. doi: 10.1016/j.clgc.2025.102316.
PubMed
Abstract available

CHEN YJ, Liu HL, Ma YH, Bai X, et al
[Value of whole-lesion apparent diffusion coefficient histogram parameters in preoperative differentiation of histological grade of bladder urothelial carcinoma].
Zhonghua Yi Xue Za Zhi. 2025;105:753-759.
PubMed
Abstract available

SEOK J, Kwak HJ, Kang CK, Kim AR, et al
Development of a technique for diagnosis and screening of superficial bladder cancer by cell-pellet DNA from urine sample.
Lab Invest. 2025 Mar 3:104124. doi: 10.1016/j.labinv.2025.104124.
PubMed
Abstract available

XIE B, Chen J, Kai J, Li J, et al
Association between drinking water disinfection byproducts exposure and human bladder cancer: A time-updated meta-analysis of trihalomethanes.
J Hazard Mater. 2025;490:137833.
PubMed
Abstract available

GUO X, Yang J, Cao R, Hao G, et al
The interplay between angiogenesis-associated genes and molecular, clinical, and immune features in bladder cancer.
Discov Oncol. 2025;16:265.
PubMed
Abstract available

SCHLACK K, Machtens S, Kubin T, Ruhnke M, et al
Real-world treatment patterns and clinical outcomes in patients with locally advanced or metastatic urothelial carcinoma in Germany: retrospective CONVINCE study.
J Cancer Res Clin Oncol. 2025;151:100.
PubMed
Abstract available

ECKE TH, Steinbach D, Becker C, Fussel S, et al
[Report on the 15th symposium of the German Research Association for Bladder Cancer (DFBK) on 24 and 25 January 2025 in Jena].
Urologie. 2025 Mar 5. doi: 10.1007/s00120-025-02556.
PubMed

SU X, Tao Y, Chen F, Han X, et al
Trends in the global, regional, and national burden of bladder cancer from 1990 to 2021: an observational study from the global burden of disease study 2021.
Sci Rep. 2025;15:7655.
PubMed
Abstract available

PECORARO M, Cipollari S, Messina E, Laschena L, et al
Multiparametric MRI for Bladder Cancer: A Practical Approach to the Clinical Application of VI-RADS.
Radiology. 2025;314:e233459.
PubMed
Abstract available

RETRACTION: Role of miR-490-3p in Blocking Bladder Cancer Growth Through Targeting the RNA-Binding Protein PCBP2.
Kaohsiung J Med Sci. 2025 Mar 4:e70009. doi: 10.1002/kjm2.70009.
PubMed
Abstract available

DURANT AM, Nguyen M, Choudry MM, Mi L, et al
Repeat TURBT in large volume high-grade non-invasive bladder cancer.
Bladder Cancer. 2024;10:270-277.
PubMed
Abstract available

CASTELLON-LOPEZ Y, Thompson PA
Achieving health equity in bladder cancer care: Addressing disparities through collaborative research and evidence-based strategies.
Bladder Cancer. 2024;10:264-269.
PubMed
Abstract available

FLESHNER N, Grossman HB, Berglund R, Hafron J, et al
North American study and meta-analysis evaluating performance of Bladder EpiCheck((R)), a FDA cleared test, in non-muscle invasive bladder cancer recurrence.
Bladder Cancer. 2025;10:278-289.
PubMed
Abstract available

KHENE ZE, Tachibana I, Bhanvadia R, Ausmann H, et al
BCG therapy for bladder cancer: Exploring patient experiences and concerns through artificial intelligence-based social media analysis.
Bladder Cancer. 2024;10:290-299.
PubMed
Abstract available

SASAKI T, Ryota I, Ishiyama A, Takakura S, et al
Muscle invasive bladder cancer treated with gemcitabine plus cisplatin as neoadjuvant chemotherapy during the second trimester of pregnancy.
IJU Case Rep. 2025;8:138-141.
PubMed
Abstract available

YOSHIHARA K, Ito K, Kimura T, Yamamoto Y, et al
Single-cell RNA sequencing and spatial transcriptome analysis in bladder cancer: Current status and future perspectives.
Bladder Cancer. 2025;11:23523735251322017.
PubMed
Abstract available

FONG KY, Lim EJ, So WZ, Aslim EJ, et al
Management of bladder cancer in kidney transplant recipients: A narrative review.
Bladder Cancer. 2025;11:23523735251321986.
PubMed
Abstract available

APOLO A, Baumann BC, Al-Ahmadie H, Ballas L, et al
Summary from the NCI clinical trials planning meeting on next generation of clinical trials in non-muscle invasive bladder cancer().
Bladder Cancer. 2025;11:23523735251319185.
PubMed
Abstract available

P SHANMUGAM S, Zhou Y, Stelter I, Hanlon T, et al
Impact of DNA repair deficiency on sensitivity to antibody-drug conjugate (ADC) payloads in bladder cancer.
Bladder Cancer. 2025;11:23523735251317865.
PubMed
Abstract available

CALLIHAN EB, Kuna EM, Eule CJ, Kessler ER, et al
Practice patterns and outcomes of conventional versus split-dose cisplatin in neoadjuvant ddMVAC in bladder cancer.
Bladder Cancer. 2025;11:23523735241310388.
PubMed
Abstract available

SINGH P, Ghorai RP, Seth A, Saini S, et al
Urachal adenocarcinoma presenting as pseudomyxoma peritonei: an unusual bladder tumour.
BMJ Case Rep. 2025;18:e258115.
PubMed
Abstract available

ALGODAYAN S, Almehaidib A, Priftakis D
123I-MIBG SPECT/CT in Evaluating Symptomatic Urinary Bladder Pheochromocytoma.
Clin Nucl Med. 2025;50:e211-e213.
PubMed
Abstract available

JURIC I, Fink EE, Qiu H, Desprez PE, et al
Single Cell RNA-sequencing of BCG naive and recurrent non-muscle invasive bladder cancer reveals a CD6/ALCAM-mediated immune-suppressive pathway.
bioRxiv [Preprint]. 2025 Feb 17:2025.02.13.638074.
PubMed
Abstract available

JIA E, Agarwal G
Clinical utility of liquid biopsy in bladder cancer: The beginning of a new era.
J Liq Biopsy. 2024;6:100271.
PubMed
Abstract available

KAO CC, Shih JW, Huynh HTLK, Chang CH, et al
Nutraceutical Evaluation of Trigonelline's Therapeutic Potential by Targeting Bladder Cancer Stem Cells and Cancer-Associated Fibroblasts via Downregulation of TGFbeta3/GLI2/YAP1 Signaling Hub.
Int J Med Sci. 2025;22:1194-1207.
PubMed
Abstract available

ZHANG J, Jia H, Han H
Emerging drivers of female bladder cancer: a pathway to precision prevention and treatment.
Front Oncol. 2025;15:1497637.
PubMed
Abstract available

IIDA H, Atsumi K, Kadoma N, Takashima S, et al
Allergic bronchopulmonary mycosis induced by pembrolizumab for bladder cancer: A case report.
Respir Med Case Rep. 2025;54:102179.
PubMed
Abstract available

ZHANG J, Fan X, Chen Y, Han Y, et al
An unfolded protein response (UPR)-signature regulated by the NFKB-miR-29b/c axis fosters tumor aggressiveness and poor survival in bladder cancer.
Front Mol Biosci. 2025;12:1542650.
PubMed
Abstract available

GAO X, Qi W, Li J, Xia Y, et al
Prognostic and predictive role of circulating tumor DNA detection in patients with muscle invasive bladder cancer: a systematic review and meta-analysis.
Cancer Cell Int. 2025;25:75.
PubMed
Abstract available

ZHAN Y, Zhou Z, Zhu Z, Zhang L, et al
Exosome-transmitted LUCAT1 promotes stemness transformation and chemoresistance in bladder cancer by binding to IGF2BP2.
J Exp Clin Cancer Res. 2025;44:80.
PubMed
Abstract available

ZHANG C, Cai H, Ye M, Wang L, et al
TCF7 functions as a prognostic biomarker in bladder cancer by strengthening EMT and stemness associated with TGF-beta/SMAD3 signaling.
Mol Cell Biochem. 2025 Mar 1. doi: 10.1007/s11010-025-05241.
PubMed
Abstract available

ATHANS SR, Withers H, Stablewski A, Gurova K, et al
STAG2 expression imparts distinct therapeutic vulnerabilities in muscle-invasive bladder cancer cells.
Oncogenesis. 2025;14:4.
PubMed
Abstract available

NIU S, Huang S, Shi M, Luo Z, et al
Discovery of new aphidicolin diterpenoids from the deep-sea-derived fungus Botryotinia fuckeliana with cytotoxic activity against human bladder cancer cells.
Bioorg Chem. 2025;157:108311.
PubMed
Abstract available

EZZAT N, Emadeldien N, Ali MK, Fahd S, et al
In vitro Evaluation of Zinc Oxide-Metformin Folic Acid Nanocomposite as a Targeted Drug Delivery System for Cancer Therapy.
Asian Pac J Cancer Prev. 2025;26:443-452.
PubMed
Abstract available

EGEMBA C, Kapil S, Ajami T, Williams A, et al
Association of metabolic syndrome and chronic kidney disease with nonmuscle invasive bladder cancer recurrence and progression.
Urol Oncol. 2025 Feb 27:S1078-1439(25)00032.
PubMed
Abstract available

ZHAO H, Zhu H, Du Y, He M, et al
Gold nanoparticles/Cu decorated metal-organic frameworks for synergistic photodynamic/ferroptosis cancer therapy.
Biomed Mater. 2025;20.
PubMed
Abstract available

SANTA F, Akgul M, Tannous E, Pacheco RR, et al
Primary adenocarcinoma of the urinary tract and its precursors: Diagnostic criteria and classification.
Hum Pathol. 2025;155:105734.
PubMed
Abstract available

JOLY F, Culine S, Roupret M, Tricotel A, et al
Epidemiology, resource use, and treatment patterns of locally advanced or metastatic urothelial carcinoma in France.
Future Oncol. 2025;21:665-679.
PubMed
Abstract available

TOBIA IP, Pedergrana C, Alfieri AG, Tejerizo JC, et al
Relationship between intraoperative intestinal cultures and postoperative urinary infection in radical cystectomy with ileal diversion patients.
Actas Urol Esp (Engl Ed). 2025;49:501703.
PubMed
Abstract available

KIM YJ, Lee J, Park S, Kim YM, et al
The value of magnetic resonance imaging in predicting vesicovaginal fistula in cervical cancer with bladder invasion treated with definitive chemoradiotherapy.
Gynecol Oncol. 2025;193:136-140.
PubMed
Abstract available

WANG Y, Sun J, Yi J, Fu R, et al
"Three-in-one" Analysis of Proteinuria for Disease Diagnosis through Multifunctional Nanoparticles and Machine Learning.
Adv Sci (Weinh). 2025;12:e2410751.
PubMed
Abstract available

FALLARA G, Belladelli F, Robesti D, Malavaud B, et al
Concomitant antihistamine administration is associated with improved survival outcomes in patients with locally advanced or metastatic urothelial carcinoma treated with atezolizumab. Analysis of individual participant data from IMvigor210 and IMvigor2
Urol Oncol. 2025;43:188.
PubMed
Abstract available

LYU T, Wu K, Zhou Y, Kong T, et al
Single-Cell RNA Sequencing Reveals the Tumor Heterogeneity and Immunosuppressive Microenvironment in Urothelial Carcinoma.
Cancer Sci. 2025;116:710-723.
PubMed
Abstract available

SCHMIDT J, Furlano K, Kellmer P, Krause H, et al
Retrospective analysis of partial cystectomy in patients with muscle-invasive urothelial carcinoma: A German single-center experience.
Urol Oncol. 2025;43:188.
PubMed
Abstract available

CHEN RC, Fuldeore R, Greatsinger A, Hepp Z, et al
Real-world survival and economic burden among patients with locally advanced or metastatic urothelial carcinoma in the United States.
Urol Oncol. 2025;43:189.
PubMed
Abstract available

MORETTO S, Piccolini A, Gallioli A, Contieri R, et al
The role of intravesical chemotherapy following nephroureterectomy in upper tract urothelial carcinoma: A systematic review and meta-analysis.
Urol Oncol. 2025;43:191.
PubMed
Abstract available

LEE A, Ong K, Al-Zubaidi M, Goodall T, et al
Development of a new radical cystectomy surveillance protocol and nurse-led cystectomy follow-up clinic in Australia.
ANZ J Surg. 2025;95.
PubMed
Abstract available

OSCAR-THOMPSON L, Riveros C, Sonpavde G, Apolo AB, et al
Adjuvant immunotherapy in high-risk muscle invasive urothelial carcinoma: A systematic review and meta-analysis of randomized clinical trials.
Urol Oncol. 2025;43:156-163.
PubMed
Abstract available

FERREIRA GM, Lima APB, Sousa JAC, Pereira GR, et al
8-Methoxy-alpha-lapachone and lawsone: antiproliferative effects on bladder tumour cells.
Nat Prod Res. 2025;39:1058-1064.
PubMed
Abstract available

TANG X, Zhou C, Lu C, Meng Y, et al
Enhancing Drug Repositioning Through Local Interactive Learning With Bilinear Attention Networks.
IEEE J Biomed Health Inform. 2025;29:1644-1655.
PubMed
Abstract available

LIU JY, Song YJ, Li PJ, Gao Y, et al
Niacin Ester Derivative of Brefeldin A as a Potential Dual-Target Arf1/BMX Inhibitor for Bladder Cancer.
J Nat Prod. 2025 Mar 14. doi: 10.1021/acs.jnatprod.5c00086.
PubMed
Abstract available

KANG NW, Lin KL, Lin KY, Feng YH, et al
Radiotherapy can significantly improve survival outcomes in patients with muscle-invasive bladder cancer who are unsuitable for cystectomy or chemoradiotherapy.
Am J Cancer Res. 2025;15:723-736.
PubMed
Abstract available

XIAO D, Chu X, Wang W, Peng M, et al
Inhibition of Cyclin D1 by Novel Biguanide Derivative YB-004 Increases the Sensitivity of Bladder Cancer to Olaparib via Causing G0 / G1 Arrest.
Int J Biol Sci. 2025;21:1984-1998.
PubMed
Abstract available

SONG Q, Wang W, Yu H, Zhou Z, et al
IGF2BP3 promotes the proliferation and cisplatin resistance of bladder cancer by enhancing the mRNA stability of CDK6 in an m6A dependent manner.
Int J Biol Sci. 2025;21:2048-2066.
PubMed
Abstract available

ZHANG C, Yu Y, Zhou Q, Ouyang J, et al
Disitamab vedotin vs. gemcitabine-cisplatin regimen with immunotherapy: a comparative analysis of efficacy and safety in muscle-invasive bladder cancer.
Front Immunol. 2025;16:1549647.
PubMed
Abstract available

MASONE MC
Chlorination by-products in drinking water - association with bladder cancer risk.
Nat Rev Urol. 2025 Mar 13. doi: 10.1038/s41585-025-01017.
PubMed

SHAO W, Cheng M, Lopez-Beltran A, Osunkoya AO, et al
Novel Computational Pipeline Enables Reliable Diagnosis of Inverted Urothelial Papilloma and Distinguishes It From Urothelial Carcinoma.
JCO Clin Cancer Inform. 2025;9:e2400059.
PubMed
Abstract available

KANG Y, Zhu Y, Zhong G, Lv A, et al
Life Experience of Patients Living With Urostomy: A Meta-Synthesis of Qualitative Research.
Psychooncology. 2025;34:e70096.
PubMed
Abstract available

SCALIA R, Gisone S, Escobar R, Proietti S, et al
Pulsed TM-YAG laser (Thulio(R)): a new weapon in endourologists' hand in the conservative management of imperative cases of Upper Tract Urothelial Carcinoma (UTUC).
Int Braz J Urol. 2025;51:e20240653.
PubMed
Abstract available

VESKIMAE E, Korgvee A, Huhtala H, Koskinen H, et al
Quadratus lumborum block is feasible alternative to epidural block for postoperative analgesia after open radical cystectomy: surgical and oncological outcomes of a randomised clinical trial.
Scand J Urol. 2025;60:59-65.
PubMed
Abstract available

AAMAND M, Brandt SB, Milling RV, Jensen JB, et al
The Impact of the Localization of Metastasis in Bladder Cancer Patients with Recurrence After Cystectomy.
Cancers (Basel). 2025;17:867.
PubMed
Abstract available

DOSHI C, Zahir M, Dadabhoy A, Escobar D, et al
Serum Tumor Markers for Muscle-Invasive Bladder Cancer in Clinical Practice: A Narrative Review.
Cancers (Basel). 2025;17:728.
PubMed
Abstract available

AKSAKALLI T, Utlu A, Celik F, Cinislioglu AE, et al
Factors predicting local or systemic side effects related to intravesical BCG (Bacillus Calmette-Guerin) therapy: a retrospective observational study.
BMC Urol. 2025;25:49.
PubMed
Abstract available

CAO C, Wang Y, Deng X, Zhao X, et al
Exosomes containing miR-152-3p targeting FGFR3 mediate SLC7A7-induced angiogenesis in bladder cancer.
NPJ Precis Oncol. 2025;9:71.
PubMed
Abstract available

FENG Z, Mei Y, Chen H, Li L, et al
Starvation-induced HBP metabolic reprogramming and STAM2 O-GlcNAcylation facilitate bladder cancer metastasis.
Sci Rep. 2025;15:8480.
PubMed
Abstract available

LIU L, Liu S, Xia X, Zheng L, et al
Association of radiotherapy with secondary pelvic cancers in male patients with rectal cancer.
Int J Colorectal Dis. 2025;40:65.
PubMed
Abstract available

ZHANG X, Li P, Ji L, Zhang Y, et al
A machine learning-based prognostic signature utilizing MSC proteomics for predicting bladder cancer prognosis and treatment response.
Transl Oncol. 2025;54:102349.
PubMed
Abstract available

STRAHL L, Borgmann H, Struck JP, Salem J, et al
Feasibility, Safety, and Patient Satisfaction of Transurethral Bladder Tumor Resection in an Outpatient Setting.
Cancer Rep (Hoboken). 2025;8:e70120.
PubMed
Abstract available

RAZAVI S, Khan A, Fu D, Mayer D, et al
Metabolic landscape in bladder cancer.
Curr Opin Oncol. 2025 Mar 12. doi: 10.1097/CCO.0000000000001137.
PubMed
Abstract available

TAKAHASHI Y, Kato D, Maeda S, Motegi T, et al
Outcomes of total cystectomy with medical treatment in canine urothelial carcinoma of the bladder trigone.
Can Vet J. 2025;66:318-326.
PubMed
Abstract available

KULKARNI GS, Guzzo T, Abbosh PH, Huang WC, et al
Real-World Treatment Patterns and Outcomes in Patients With Bacillus Calmette-Guerin-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer: A Multicountry Medical Chart Review.
Clin Genitourin Cancer. 2025;23:102313.
PubMed
Abstract available

HERR H
Neoadjuvant Chemotherapy and Partial Cystectomy for Muscle-Invasive Bladder Cancer - 20-year bladder-preserved survival.
Urol Pract. 2025 Mar 11:101097UPJ0000000000000807.
PubMed

YAN B, Liu Y, Liu Y, Zheng J, et al
Intracorporeal versus extracorporeal neobladder in robot-assisted radical cystectomy: perioperative, oncological, and functional outcomes from a single-institutional experience.
World J Urol. 2025;43:160.
PubMed
Abstract available

SCHNEIDEWIND L, Sommerhalder B, Willi D, Ronnau C, et al
[Association of glitazones and bladder cancer: a rapid review].
Urologie. 2025 Mar 11. doi: 10.1007/s00120-025-02557.
PubMed
Abstract available

YAJIMA S, Hirose K, Masuda H
Enfortumab Vedotin With or Without Pembrolizumab in Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
JAMA Netw Open. 2025;8:e250250.
PubMed
Abstract available

VATANKHAH MA, Ziyabakhsh A, Vakili Ojarood M
Regulation of Apoptosis, Autophagy, and Metastasis by Luteolin in Human Bladder Cancer EJ138 Cells: An Experimental Study.
Iran J Pharm Res. 2024;23:e153408.
PubMed
Abstract available

HAN X, Guan J, Guo L, Jiao Q, et al
A CT-based interpretable deep learning signature for predicting PD-L1 expression in bladder cancer: a two-center study.
Cancer Imaging. 2025;25:27.
PubMed
Abstract available

ALTUNKOL A, Alma E, Vuruskan E, Cetinkoku G, et al
Health-related quality of life after radical cystectomy for bladder cancer in elderly patients with ileal orthotopic neobladder, ureterocutaneostomy or ileal conduit: cross-sectional study using validated questionnaires.
BMC Urol. 2025;25:46.
PubMed
Abstract available

JONOSKY J, Adam A, Wadee R
A histopathological snapshot of bladder cancer: a Johannesburg experience of 1480 histopathology reports.
World J Urol. 2025;43:159.
PubMed
Abstract available

FORDE K, Juliebo-Jones P, Alvsvag H, Orskov B, et al
A qualitative study exploring the experiences of nurses delivering bacillus Calmette-Guerin therapy.
Br J Nurs. 2025;34:S4-S8.
PubMed
Abstract available

MATSUSHITA Y, Tsuchiya Y, Ishikawa G, Sano A, et al
Comparing oncological outcomes and safety between photodynamic diagnosis-assisted and white-light transurethral resection in elderly patients with non-muscle invasive bladder cancer.
Jpn J Clin Oncol. 2025 Mar 10:hyaf047. doi: 10.1093.
PubMed
Abstract available

LIU L, Zhang PY, Xiao Y, Wang Q, et al
Prognostic Factors Influencing Postoperative Survival in Patients With Neuroendocrine Carcinoma of the Bladder: A Population-Based Study.
Cancer Med. 2025;14:e70758.
PubMed
Abstract available

WANG L, Kou Z, Zhu J, Zhu X, et al
PRR11 Promotes Bladder Cancer Growth and Metastasis by Facilitating G1/S Progression and Epithelial-Mesenchymal Transition.
Cancer Med. 2025;14:e70749.
PubMed
Abstract available

WIESEN B, Hargis P, Flores H, Kukreja J, et al
Updated review on novel therapies and ongoing clinical trials for high-risk non-muscle invasive bladder cancer.
Front Oncol. 2025;15:1519428.
PubMed
Abstract available

OU J, Bi H, Zhou H, Zhang Z, et al
Sex-specific associations of sex hormone binding globulin and risk of bladder cancer.
Open Med (Wars). 2025;20:20251163.
PubMed
Abstract available

LV R, Liu Z, Lv M, Song Y, et al
Neoantigen immunotherapy: a novel treatment for bladder cancer.
Explor Target Antitumor Ther. 2025;6:1002288.
PubMed
Abstract available

HUANG W, Wang T, Chao F, Yang Q, et al
ImmunoPET Imaging of Trop2 Expression in Bladder Cancer Using [(64)Cu]Cu-NOTA-Trodelvy.
Mol Pharm. 2025 Mar 9. doi: 10.1021/acs.molpharmaceut.5c00069.
PubMed
Abstract available

CAO L, Huang LG, Zhang LH, Yang G, et al
A systematic review and meta-analysis of intracorporeal versus extracorporeal urinary diversion after robotic-assisted radical cystectomy in elderly patients with malignancy.
J Robot Surg. 2025;19:106.
PubMed
Abstract available

MI G, Ma Y, Liu L, Liao B, et al
Optimal energy source selection strategies for en bloc resection in non-muscle invasive bladder cancer: a systematic review and network meta-analysis.
World J Urol. 2025;43:155.
PubMed
Abstract available

YOU C, Fang Q, Xiao X, Liu Y, et al
ENPP1 promotes immune suppression, drug resistance, and adverse outcomes in bladder cancer: Potential for targeted therapy.
Cancer Genet. 2025;294-295:1-14.
PubMed
Abstract available

LI Y, Yang W, Chen H, Jin Z, et al
Comprehensive pan-cancer single-cell analysis reveals glycolysis-related signatures as predictive biomarkers for immunotherapy response and their role in bladder Cancer.
Int Immunopharmacol. 2025;152:114381.
PubMed
Abstract available

YAO JM, Zhong JL, Zhou Q, Guo J, et al
Efficacy and safety of disitamab vedotin in combination with immune checkpoint inhibitors in patients with locally advanced or metastatic urothelial carcinoma.
World J Urol. 2025;43:154.
PubMed
Abstract available

NOWAK D, Kloskowski T, Goslinski M, Buhl M, et al
Antioxidant Properties of Aronia melanocarpa and Morinda citrifolia Juices and their Impact on Bladder Cancer Cell Lines.
Med Sci Monit. 2025;31:e945120.
PubMed
Abstract available

GUO S, Lv G, Zhu H, Guo Y, et al
Disulfidptosis related immune genes drive prognostic model development and tumor microenvironment characterization in bladder urothelial carcinoma.
Sci Rep. 2025;15:8130.
PubMed
Abstract available

LI Y, Fu B, Wang M, Chen W, et al
Urinary extracellular vesicle N-glycomics identifies diagnostic glycosignatures for bladder cancer.
Nat Commun. 2025;16:2292.
PubMed
Abstract available

CHEN K, Li X, Liu L, Wang B, et al
Correlation of noninvasive imaging of tumour-infiltrating lymphocytes with survival and BCG immunotherapy response in patients with bladder cancer: a multicentre cohort study.
Int J Surg. 2025;111:920-931.
PubMed
Abstract available

GIANNATEMPO P, Machiels JP, Sassa N, Arranz JA, et al
Impact of Histology on Clinical Outcomes of Pembrolizumab Monotherapy in Patients With Advanced or Metastatic Urothelial Carcinoma in the Phase 3 KEYNOTE-045 and KEYNOTE-361 Trials.
Clin Genitourin Cancer. 2025;23:102273.
PubMed
Abstract available

GABRIEL PE, Gauthier H, Xylinas E, Hermieu JF, et al
Isolated Urinary Tract Persistence or Progression in Patients Treated With Immunotherapy for Advanced Urothelial Carcinoma.
Clin Genitourin Cancer. 2025;23:102312.
PubMed
Abstract available

HOSSAIN MK, Unger L, Larsen U, Altankhuyag A, et al
Mapping the initial effects of carcinogen-induced oncogenic transformation in the mouse bladder.
Exp Cell Res. 2025;446:114452.
PubMed
Abstract available

KAMBLE TS, Wang H, Myers N, Littlefield N, et al
Predicting cancer survival at different stages: Insights from fair and explainable machine learning approaches.
Int J Med Inform. 2025;197:105822.
PubMed
Abstract available

XU J, Wang H, Lu M, Bi H, et al
An accurate and trustworthy deep learning approach for bladder tumor segmentation with uncertainty estimation.
Comput Methods Programs Biomed. 2025;263:108645.
PubMed
Abstract available

VAN WILPE S, Croci D, Fonseca Costa SS, Te Paske IB, et al
Multimodal integration of blood RNA and ctDNA reflects response to immunotherapy in metastatic urothelial cancer.
JCI Insight. 2025;10:e186062.
PubMed
Abstract available

NAKAMURA Y, Tanaka H, Numao N, Inoue M, et al
Enfortumab Vedotin for Metastatic Urothelial Carcinoma: Comprehensive Treatment Outcomes and Prognostic Insights From a Multicenter Real-World Study (YUSHIMA Study).
Clin Genitourin Cancer. 2025;23:102301.
PubMed
Abstract available

SHINDO T, Hashimoto K, Kenuka T, Miyamoto S, et al
Efficacy and safety of enfortumab vedotin in older patients with metastatic urothelial carcinoma: A multicenter retrospective study.
J Geriatr Oncol. 2025;16:102183.
PubMed
Abstract available

BALCIK OY, Yilmaz F
FOXP3/TLS; a prognostic marker in patients with bladder carcinoma without muscle invasion.
Urol Oncol. 2025;43:268.
PubMed
Abstract available

LAMA DJ, Okunowo O, Yamzon J, Zhumkhawala AA, et al
Long-term oncologic outcomes and complications of robot-assisted radical cystectomy for the treatment of urothelial carcinoma of the bladder.
Urol Oncol. 2025;43:267.
PubMed
Abstract available

LI J, Mahmood AW, Ahmed Z, Giangrasso A, et al
Tumor involvement of the trigone and urethra at the time of robot-assisted radical cystectomy is associated with adverse oncological outcomes.
Urol Oncol. 2025;43:268.
PubMed
Abstract available

WOOD AM, Benidir T, Campbell R, Li J, et al
Quantification of micropapillary component on transurethral resection is associated with likelihood of occult lymph node metastasis at radical cystectomy.
Urol Oncol. 2025;43:266.
PubMed
Abstract available

SONG Y, Peng Y, Qin C, Jiang S, et al
Antibiotic use attenuates response to immune checkpoint blockade in urothelial carcinoma via inhibiting CD74-MIF/COPA: revealing cross-talk between anti-bacterial immunity and ant-itumor immunity.
Int J Surg. 2025;111:972-987.
PubMed
Abstract available

CHEN L, He C, Ou Z, Zhao C, et al
TNF-alpha drives bladder cancer metastasis via METTL3-mediated m6A modification to promote CLASP2/IQGAP1-dependent cytoskeleton remodeling.
Biochim Biophys Acta Mol Basis Dis. 2025 Mar 19:167811.
PubMed
Abstract available

AVUDAIAPPAN AP, Prabhakar P, Fleischmann B, Rubens M, et al
Survival analysis comparing bladder preservation techniques in octogenarians with muscle-invasive bladder cancer.
Transl Androl Urol. 2025;14:280-288.
PubMed
Abstract available

YU F, Yu N, Zhang L, Xu X, et al
Emodin Decreases Tumor-Associated Macrophages Accumulation and Suppresses Bladder Cancer Development by Inhibiting CXCL1 Secretion from Cancer-Associated Fibroblasts.
Nutr Cancer. 2025 Mar 20:1-16. doi: 10.1080/01635581.2025.2480309.
PubMed
Abstract available

MOU Y, Mao Y, Liu Z, Zhang P, et al
Robot-assisted radical cystectomy with the clinical application of "Y-shaped" end-to-side ureteral anastomosis in elderly and obese patients.
BMC Urol. 2025;25:56.
PubMed
Abstract available

XU J, Xu J, Sun C, He X, et al
Effective Delivery of CRISPR/dCas9-SAM for Multiplex Gene Activation Based on Mesoporous Silica Nanoparticles for Bladder Cancer Therapy.
Acta Biomater. 2025 Mar 18:S1742-7061(25)00205.
PubMed
Abstract available

ZHAO H, Gao X, Jiang Y, Yu Y, et al
Targeting COPA to Enhance Erdafitinib Sensitivity in FGFR-Altered Bladder Cancer.
Adv Sci (Weinh). 2025 Mar 20:e2413209. doi: 10.1002/advs.202413209.
PubMed
Abstract available

SLUSARCZYK A, Scilipoti P, Marcq G, Pradere B, et al
Comparison of extended and standard lymph node dissection in radical cystectomy for urothelial bladder cancer: a systematic review and meta-analysis.
World J Urol. 2025;43:181.
PubMed
Abstract available

JIAN N, Yu L, Ma L, Zheng B, et al
BCG therapy in bladder cancer and its tumor microenvironment interactions.
Clin Microbiol Rev. 2025 Mar 20:e0021224. doi: 10.1128/cmr.00212.
PubMed
Abstract available

KHATTAK AA, Javed A, Pokhrel P, Mukhtar S, et al
Transforming non-muscle invasive bladder cancer (NMIBC) treatment: FDA approval of Anktiva in combination with BCG.
Ann Med Surg (Lond). 2025;87:457-459.
PubMed

XIAO J, Liu W, Gong J, Lai W, et al
Integrated single-cell analysis reveals the regulatory network of disulfidptosis-related lncRNAs in bladder cancer: constructing a prognostic model and predicting treatment response.
Front Oncol. 2025;15:1527036.
PubMed
Abstract available

FRANCESCA B, Meo M, Giudice FD, Scornajenghi CM, et al
Exploring the utility of a NGS multigene panel to predict BCG response in patients with non-muscle invasive bladder cancer.
Oncol Res. 2025;33:723-731.
PubMed
Abstract available

MIHAI IM, Wang G
Biomarkers for predicting bladder cancer therapy response.
Oncol Res. 2025;33:533-547.
PubMed
Abstract available

MIYAKE M, Iida K, Nishimura N, Ohnishi S, et al
Serum metabolomic analysis identified serum biomarkers predicting tumour recurrence after Bacillus Calmette-Guerin therapy in patients with non-muscle invasive bladder cancer.
Bladder Cancer. 2025;11:23523735251325100.
PubMed
Abstract available

DAI H, Zhang X, Zhao Y, Nie J, et al
ADME gene-driven prognostic model for bladder cancer: a breakthrough in predicting survival and personalized treatment.
Hereditas. 2025;162:42.
PubMed
Abstract available

MERO S, Oberneder K, Weiss J, Grobet-Jeandin E, et al
Radiofrequency induced hyperthermia in non-muscle invasive bladder cancer: Oncologic outcomes in a real-world scenario.
Actas Urol Esp (Engl Ed). 2025 Mar 17:501746. doi: 10.1016/j.acuroe.2025.501746.
PubMed
Abstract available

XIE X, He H, Zhang N, Wang X, et al
DDR1 Targeting HOXA6 Facilitates Bladder Cancer Progression via Inhibiting Ferroptosis.
J Cell Mol Med. 2025;29:e70410.
PubMed
Abstract available

CHEN X, Diao W, Guo X, Cao W, et al
The N6-methyladenosine reader IGF2BP3 promotes bladder cancer progression through enhancing HSP90AB1 expression.
FEBS J. 2025 Mar 19. doi: 10.1111/febs.70068.
PubMed
Abstract available

LIU Z, Zhang H, Luo R, Wang B, et al
Clinical characterization and prognostic modeling of bladder cancer patients with a history of prior tumors: a SEER database analysis.
Transl Cancer Res. 2025;14:1111-1123.
PubMed
Abstract available

BEN MUVHAR R, Paluch R, Mekayten M
Recent Advances and Emerging Innovations in Transurethral Resection of Bladder Tumor (TURBT) for Non-Muscle Invasive Bladder Cancer: A Comprehensive Review of Current Literature.
Res Rep Urol. 2025;17:69-85.
PubMed
Abstract available

SHI Y, Fan G, Yang E, Zhang Y, et al
Enhanced efficacy of immune checkpoint inhibitors by folate-targeted multifunctional drug through synergistic therapy inducing ferroptosis and immunogenic cell death in bladder cancer.
Mater Today Bio. 2025;31:101584.
PubMed
Abstract available

HE X, Chen Y, Zhou S, Wang G, et al
A Machine Learning Model Based on Multi-Phase Contrast-enhanced CT for the Preoperative Prediction of the Muscle-Invasive Status of Bladder Cancer.
Curr Med Imaging. 2025 Mar 17. doi: 10.2174/0115734056377754250304040058.
PubMed
Abstract available

THAKUR A, Kumar L, Agarwal S, Tripathy R, et al
Assessing the clinical efficacy of neoadjuvant intravesical Mitomycin C in naive non-muscle invasive urinary bladder cancer: A systematic review and meta-analysis.
Curr Probl Cancer. 2025 Mar 17:101198.
PubMed
Abstract available

GALARZA FORTUNA GM, Grass D, Maughan BL, Jain RK, et al
Nivolumab adjuvant to chemo-radiation in localized muscle-invasive urothelial cancer: primary analysis of a multicenter, single-arm, phase II, investigator-initiated trial (NEXT).
J Immunother Cancer. 2025;13:e010572.
PubMed
Abstract available

ASLAN S, Tasdemir MN, Cakir E, Oguz U, et al
Predicting variant histology in bladder cancer: the role of multiparametric MRI and vesical imaging-reporting and data system (VI-RADS).
Abdom Radiol (NY). 2025 Mar 18. doi: 10.1007/s00261-025-04852.
PubMed
Abstract available

LI KP, Wang L, Wan S, Wang CY, et al
Enhanced Artificial Intelligence in Bladder Cancer Management: A Comparative Analysis and Optimization Study of Multiple Large Language Models.
J Endourol. 2025 Mar 18. doi: 10.1089/end.2024.0860.
PubMed
Abstract available

LI B, Gan J, Li T, Chen J, et al
Comprehensive analysis of RNA methylation-related genes to identify molecular cluster for predicting prognosis and immune profiles in bladder cancer.
Sci Rep. 2025;15:9147.
PubMed
Abstract available

WANG C, Wan S, Li K, Chen S, et al
TPI1 promotes p53 ubiquitination in bladder cancer by recruiting AKT to enhance MDM2 phosphorylation.
Pharmacol Res. 2025;215:107695.
PubMed
Abstract available

MANCON S, Matsukawa A, Cadenar A, Tsuboi I, et al
Impact of opium on bladder cancer incidence: A systematic review and meta-analysis.
Actas Urol Esp (Engl Ed). 2025 Mar 15:501749. doi: 10.1016/j.acuroe.2025.501749.
PubMed
Abstract available

ZHANG X, Zhang B, He Y, Xiong W, et al
A nomogram based on preoperative NLR predicts distant metastasis of urothelial carcinoma of the bladder.
Cancer Biomark. 2024;41.
PubMed
Abstract available

JIANG F, Hong G, Zeng H, Lin Z, et al
Deep learning-based model for prediction of early recurrence and therapy response on whole slide images in non-muscle-invasive bladder cancer: a retrospective, multicentre study.
EClinicalMedicine. 2025;81:103125.
PubMed
Abstract available

ZHANG L, Chen Y, Liao H
Efficacy and safety of Solifenacin combined with Mirabegron in treating overactive bladder in female patients following bladder instillation for bladder cancer.
Am J Transl Res. 2025;17:1144-1152.
PubMed
Abstract available

ALQARNI KA
Recent Advances in Immunotherapy for Bladder Cancer Treatment.
Cureus. 2025;17:e79002.
PubMed
Abstract available

ZHANG X, Chen Z, He X, Wang J, et al
SUMOylation of SETD8 Promotes Tumor Growth by Methylating and Stabilizing MYC in Bladder Cancer.
Adv Sci (Weinh). 2025 Mar 16:e2501734. doi: 10.1002/advs.202501734.
PubMed
Abstract available

CHENG M, Zhang L, Han X, Xu H, et al
High-fidelity telomerase activity assay based on light-triggered nucleic acid separation system for the diagnosis of bladder cancer.
Biosens Bioelectron. 2025;278:117355.
PubMed
Abstract available

DAI C, Li Q, Wang L, Zhang J, et al
Correction: FENDRR Represses Bladder Cancer Cell Proliferation, Stemness, Migration, Invasion, and EMT Process by Targeting miR-18a-5p/AFF4 Axis.
Biochem Genet. 2025 Mar 15. doi: 10.1007/s10528-025-11065.
PubMed

INCORVAIA L, Scagliarini S, Marques Monteiro FS, Takeshita H, et al
Sex as modifier of survival in patients with advanced urothelial cancer treated with pembrolizumab.
Sci Rep. 2025;15:8815.
PubMed
Abstract available

WALKER GE, Borroni E, Haider R, Olgasi C, et al
Factor VIII a coagulation co-factor is a relevant survival factor in bladder cancer cell lines.
J Thromb Haemost. 2025 Mar 12:S1538-7836(25)00142.
PubMed
Abstract available

DERNBACH G, Eich ML, Dragomir MP, Anders P, et al
Spatial expression of HER2, NECTIN4, and TROP-2 in Muscle-Invasive Bladder Cancer and metastases: Implications for pathological and clinical management.
Mod Pathol. 2025 Mar 12:100753. doi: 10.1016/j.modpat.2025.100753.
PubMed
Abstract available

TAOKA R, Fukuhara H, Miyake M, Kobayashi K, et al
Efficacy of photodynamic diagnosis for non-muscle invasive bladder cancer: Exploratory subject-based analysis in a prospective, single-arm, multicenter phase III trial.
Photodiagnosis Photodyn Ther. 2025;53:104554.
PubMed
Abstract available

LIN S, Duan L, Xu X, Cao H, et al
Analyzing Online Search Trends for Kidney, Prostate, and Bladder Cancers in China: Infodemiology Study Using Baidu Search Data (2011-2023).
JMIR Cancer. 2025;11:e57414.
PubMed
Abstract available

KOBAYASHI S, Kashiwagi H, Kobayashi K, Kohzaki M, et al
4,4'-methylenebis(2-chloroaniline) induces chromosome aneuploidy associated with premature chromatid separation in mammalian cells: A possible carcinogenic mechanism.
Ecotoxicol Environ Saf. 2025;293:117981.
PubMed
Abstract available

GRANDE E, Hussain SA, Barthelemy P, Kanesvaran R, et al
Individualizing first-line treatment for advanced urothelial carcinoma: A favorable dilemma for patients and physicians.
Cancer Treat Rev. 2025;134:102900.
PubMed
Abstract available

ALMEIDA P, Alves I, Fernandes A, Lima C, et al
"Mannose glycans as key players in trained immunity: A novel anti-tumoral catalyst".
Biochim Biophys Acta Gen Subj. 2025;1869:130779.
PubMed
Abstract available

FA YC, Chen CC, Liu YC, Lu YH, et al
Precise identification of bladder tumors utilizing mucoadhesive thiolated hollow mesoporous silica nanoparticles.
J Control Release. 2025;380:1127-1140.
PubMed
Abstract available

ALBISINNI S, Orecchia L, Mjaess G, Aoun F, et al
Enhanced Recovery After Surgery for patients undergoing radical cystectomy: Surgeons' perspectives and recommendations ten years after its implementation.
Eur J Surg Oncol. 2025;51:109543.
PubMed
Abstract available

HOTTA Y, Yoshioka N, Sakamoto A, Inagaki M, et al
Late-onset disseminated BCG infection with hepatosplenomegaly after intravesical BCG immunotherapy in a non-immunocompromised patient.
Clin J Gastroenterol. 2025;18:337-342.
PubMed
Abstract available

SCHONMANN Y, Cohen NT, Czarnowicki T
Evaluating cancer risk in a large cohort of 25,008 patients with vitiligo: Insights from a comprehensive cohort population-based study.
J Am Acad Dermatol. 2025;92:741-752.
PubMed
Abstract available

TUNG MC, Chang GM, Dai WC, Hsu CH, et al
Cryptotanshinone Suppresses the STAT3/BCL-2 Pathway to Provoke Human Bladder Urothelial Carcinoma Cell Death.
Environ Toxicol. 2025;40:624-635.
PubMed
Abstract available

KAYRAKLIOGLU N, Chan E, Bastian B, Long SR, et al
Primary Melanoma of the Urinary Bladder: Clinical, Histopathologic, and Comprehensive Molecular Analysis of a Rare Tumor.
Int J Surg Pathol. 2025;33:477-483.
PubMed
Abstract available

MISHRA M, Ayyanar P, Tripathy SR, Das MK, et al
Urothelial Carcinoma with Trophoblastic Differentiation-A Report with Review.
Int J Surg Pathol. 2025;33:490-494.
PubMed
Abstract available

GUTIERREZ PEREZ C, Lastra Aras E, Saiz Lopez P, Garcia Toro E, et al
Single-center analysis of a real-world cohort of patients with metastatic urothelial carcinoma evaluated by NGS: molecular landscape and efficacy of targeted therapies.
Clin Transl Oncol. 2025;27:1211-1220.
PubMed
Abstract available

LENG X, Chen H, Chen G
Construction and validation of a reliable disulfidptosis-related lncRNAs signature of the subtype, prognostic, and immune landscape in bladder cancer.
Discov Oncol. 2025;16:418.
PubMed
Abstract available

PEREZ M, Lozano JJ, Ingelmo-Torres M, Domenech M, et al
Biomarker-Based Nomogram to Predict Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer.
Biomedicines. 2025;13:740.
PubMed
Abstract available

KAST RE
UBC4: A Repurposed Drug Regimen for Adjunctive Use During Bladder Cancer Treatment.
Biomedicines. 2025;13:706.
PubMed
Abstract available

TOBISAWA Y, Nakane K, Koie T, Taniguchi T, et al
Low GCNT2/I-Branching Glycan Expression Is Associated with Bladder Cancer Aggressiveness.
Biomedicines. 2025;13:682.
PubMed
Abstract available

WANG T, Guo T, Sun J, Zang X, et al
Loss of OBSCN expression promotes bladder cancer progression but enhances the efficacy of PD-L1 inhibitors.
Cell Biosci. 2025;15:40.
PubMed
Abstract available

WANG J, Yang L, Du S, Pan Y, et al
Correlation between thyroid hormone levels and the incidence and staging of bladder cancer.
Eur J Med Res. 2025;30:211.
PubMed
Abstract available

AFZAL A, Liu YY, Noureen A, Rehman A, et al
Epidemiology of gall bladder cancer and its prevalence worldwide: a meta-analysis.
Orphanet J Rare Dis. 2025;20:143.
PubMed
Abstract available

WAHAFU W, Zhou Q, Yang X, Yang Y, et al
Spatial relationships and interactions of immune cell niches are linked to the pathologic response of muscle-invasive bladder cancer to neoadjuvant therapy.
J Transl Med. 2025;23:375.
PubMed
Abstract available

FAN G, Ma J, Wu Y, Wang J, et al
Robotic versus open surgery for ureteroenteric stricture after radical cystectomy: a systematic review and meta-analysis.
J Robot Surg. 2025;19:130.
PubMed
Abstract available

ZUO J, Chen J, Tan Z, Zhu X, et al
Analysis of long-term trends and 15-year predictions of smoking-related bladder cancer burden in china across different age and sex groups from 1990 to 2021.
Discov Oncol. 2025;16:408.
PubMed
Abstract available

RUTHERFORD C, Tait MA, Costa DSJ, King MT, et al
Development and psychometric evaluation of a patient-reported symptom index for patients with non-muscle invasive bladder cancer: the NMIBC-SI.
J Patient Rep Outcomes. 2025;9:36.
PubMed
Abstract available

MANCON S, Soria F, Hurle R, Enikeev D, et al
Association of energy source with outcomes in en bloc TURB: secondary analysis of a randomized trial.
World J Urol. 2025;43:191.
PubMed
Abstract available

GAO Z, Zhang L, Li Z, Qin X, et al
Visceral Adipose Predicts Prognosis and Toxicities in Locally Advanced Bladder Cancer Patients Treated With Adjuvant Gemcitabine Plus Cisplatin Chemotherapy.
Cancer Med. 2025;14:e70742.
PubMed
Abstract available

CIANFLONE F, Tartara A, Aretano L, Da Prat V, et al
Effect of Perioperative Immunonutrition on Early-Postoperative Complications in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Case Series.
J Clin Med. 2025;14:1992.
PubMed
Abstract available

KUS F, Guven DC, Yildirim HC, Chalabiyev E, et al
Comparative Analysis of Prognostic Potential of Pretreatment Blood-Based Biomarkers in Metastatic Bladder Cancer: Modified Glasgow Prognostic Score.
J Clin Med. 2025;14:1954.
PubMed
Abstract available

NESIU A, Novacescu D, Latcu S, Bardan R, et al
Diagnostic Performance and Interobserver Agreement of the Vesical Imaging-Reporting and Data System (VI-RADS) in Bladder Cancer Staging: A Systematic Review.
Medicina (Kaunas). 2025;61:469.
PubMed
Abstract available

BARKAY O, Keskin E
Intravesical BCG: A Double-Edged Sword? The Untold Story of Infection Risks.
Medicina (Kaunas). 2025;61:379.
PubMed
Abstract available

XU H, Zhang Y, Zhang Z, Wang J, et al
Development and validation of a nomogram for predicting prostatic urethral involvement in bladder cancer.
Sci Rep. 2025;15:10431.
PubMed
Abstract available

RETRACTION: Impacts of Enhanced Recovery After Surgery Nursing Interventions on Wound Infection and Complications Following Bladder Cancer Surgery: A Meta-Analysis.
Int Wound J. 2025;22:e70449.
PubMed
Abstract available

SAIDANI B, Boubaker NS, Chakroun M, Ayed H, et al
FGFR3 gene mutations screening in non-muscle invasive bladder cancer (NMIBC) in the Tunisian population.
Mol Biol Rep. 2025;52:338.
PubMed
Abstract available

NALKIRAN I, Sevim Nalkiran H
Repurposing ProTAME for Bladder Cancer: A Combined Therapeutic Approach Targeting Cell Migration and MMP Regulation.
Biology (Basel). 2025;14:263.
PubMed
Abstract available

LIU C, Deng Y, Huang L, Nie X, et al
USP5 Suppresses Ferroptosis in Bladder Cancer Through Stabilization of GPX4.
Curr Issues Mol Biol. 2025;47:211.
PubMed
Abstract available

PENG L, Zhao A, Li R, Liu Y, et al
Self-Propelled In Situ Polymerized Nanoparticles Activating the STING Pathway for Enhanced Bladder Cancer Immunotherapy.
Adv Sci (Weinh). 2025 Mar 26:e2502750. doi: 10.1002/advs.202502750.
PubMed
Abstract available

GODLEWSKI D, Bartusik-Aebisher D, Czech S, Szpara J, et al
Bladder cancer biomarkers.
Explor Target Antitumor Ther. 2025;6:1002301.
PubMed
Abstract available

LI J, Lv Y, Xue S, Li W, et al
Ailanthone inhibits bladder cancer tumor and cell proliferation, epithelial-mesenchymal transition, and activation of the Janus kinase/signal transducer and activator of transcription 3 signaling pathway.
Cytojournal. 2025;22:16.
PubMed
Abstract available

SUN N, Wang S, Liu J, Zhang P, et al
XIAP promotes metastasis of bladder cancer cells by ubiquitylating YTHDC1.
Cell Death Dis. 2025;16:205.
PubMed
Abstract available

ZENGER M, Zellweger T, Belenyesi Z, Kurz M, et al
Urogenital infection with M. bovis BCG most probably as a result of BCG instillation 21 years ago.
BMJ Case Rep. 2025;18:e260496.
PubMed
Abstract available

SAADH MJ, Hussein WS, Al-Hussainy AF, Bishoyi AK, et al
Circular RNAs: driving forces behind chemoresistance and immune evasion in bladder cancer.
Naunyn Schmiedebergs Arch Pharmacol. 2025.
PubMed
Abstract available

ULLEN A, Aljabery F, Dahlman P, Falkman K, et al
Swedish national guidelines on urothelial carcinoma: 2024 update on advanced and metastatic disease.
Scand J Urol. 2025;60:76-82.
PubMed
Abstract available

BOBAN T, Milic Roje B, Knezovic D, Jeroncic A, et al
Urinary microbiota changes among NMIBC patients during BCG therapy: comparing BCG responders and non-responders.
Front Cell Infect Microbiol. 2025;15:1479795.
PubMed
Abstract available

GONG Z, Liu Z, Zhu J, Zhao Z, et al
Global research trends and hotspots on imaging of bladder cancer: A bibliometric and visual analysis from 1981 to 2023.
Medicine (Baltimore). 2025;104:e41907.
PubMed
Abstract available

CHENG Y, Sun Q, Chen Y, Wang J, et al
DTX3 suppresses bladder cancer cell invasion and metastasis by inhibiting the Notch signaling pathway.
Int Immunopharmacol. 2025;153:114529.
PubMed
Abstract available

SELVARAJU A, Patbamniya NK, Kumar M, Seth A, et al
Preoperative prediction of muscle invasion in bladder cancer in the Indian population using the Vesical Imaging-Reporting and Data System (VI-RADS) score and individual multiparametric magnetic resonance imaging (MRI) characteristics.
Clin Radiol. 2025;84:106862.
PubMed
Abstract available

BOURGI A, Ghanem O, Brocail C, Bruyere F, et al
Is There Always a Need to Perform Urine Culture before Bacillus Calmette-Guerin Instillation for Bladder Cancer?
Surg Infect (Larchmt). 2025 Mar 24:0. doi: 10.1089/sur.2024.
PubMed
Abstract available

ZIANI I, Ibrahimi A, Nouini Y
Ureterocele with embedded stone suggesting a diagnosis of bladder tumor: beware of the diagnostic trap! (case report and literature review).
Pan Afr Med J. 2024;49:119.
PubMed
Abstract available

MESSING EM
Standard vs extended lymphadenectomy for muscle invasive bladder cancer.
Bladder Cancer. 2025;11:23523735251314984.
PubMed

QI T, He F, Wu S, Wang Q, et al
2'-Hydroxyflavanone inhibits bladder cancer cell proliferation and angiogenesis via regulating miR-99a-5p/mTOR signaling.
Am J Clin Exp Urol. 2025;13:20-32.
PubMed
Abstract available

SINGH V, Singh MK, Kumar A, Sahu DK, et al
Metabolomic Biomarkers for Prognosis in Non-Muscle Invasive Bladder Cancer: A Comprehensive Systematic Review and Meta-Analysis.
Indian J Clin Biochem. 2025;40:176-190.
PubMed
Abstract available

SINGH R, Singh UP, Agrawal V, Garg M, et al
Retraction Note: Epithelial-to-mesenchymal transition based diagnostic and prognostic signature markers in non-muscle invasive and muscle invasive bladder cancer patients.
Mol Biol Rep. 2025;52:334.
PubMed

TENG F, Zhang R, Wang Y, Li Q, et al
Machine Learning and Mendelian Randomization Reveal a Tumor Immune Cell Profile for Predicting Bladder Cancer Risk and Immunotherapy Outcomes.
Am J Pathol. 2025 Mar 21:S0002-9440(25)00077.
PubMed
Abstract available

WU Y, Xu Z, Wang R, Bai Y, et al
Prognostic biomarker PSMD14 facilitates bladder cancer tumorigenesis and progression by regulating Nucleolin-YAP1 axis.
Transl Oncol. 2025;55:102370.
PubMed
Abstract available

BAI Z, Osman M, Brendel M, Tangen CM, et al
Predicting response to neoadjuvant chemotherapy in muscle-invasive bladder cancer via interpretable multimodal deep learning.
NPJ Digit Med. 2025;8:174.
PubMed
Abstract available

CAI L, Yang X, Yu J, Shao Q, et al
Deep learning on T2WI to predict the muscle-invasive bladder cancer: a multi-center clinical study.
Sci Rep. 2025;15:9942.
PubMed
Abstract available

LIN F, Hu S, Chen J, Li H, et al
MiR-125b suppresses bladder Cancer cell growth and triggers apoptosis by regulating IL-6/IL-6R/STAT3 axis in vitro and in vivo.
Cytokine. 2025;190:156926.
PubMed
Abstract available

MAO W, Zhang H, Ji J, Wu J, et al
Protocol for single-cell RNA sequencing and spatial transcriptomics of bladder Ewing sarcoma.
STAR Protoc. 2025;6:103687.
PubMed
Abstract available

UCHIMOTO T, Iwatsuki K, Komura K, Fukuokaya W, et al
Association of body mass index and tumor response in metastatic urothelial carcinoma treated with enfortumab vedotin: data from the ULTRA-Japan consortium.
Int J Clin Oncol. 2025;30:761-769.
PubMed
Abstract available

BENJAMIN DJ, Rezazadeh Kalebasty A, Mar N
Implications and Lessons from the Withdrawal of Sacituzumab Govitecan for Treating Advanced Urothelial Carcinoma.
Eur Urol Oncol. 2025;8:242-244.
PubMed
Abstract available

MANDRIK O, Thomas C, Akpan E, Catto JWF, et al
Home Urine Dipstick Screening for Bladder and Kidney Cancer in High-Risk Populations in England: A Microsimulation Study of Long-Term Impact and Cost-Effectiveness.
Pharmacoeconomics. 2025;43:441-452.
PubMed
Abstract available

SAINI D, Chaudhary PK, Chaudhary JK, Kaur H, et al
Molecular mechanisms of antiproliferative and pro-apoptotic effects of essential oil active constituents in MCF7 and T24 cancer cell lines: in vitro insights and in silico modelling of proapoptotic gene product-compound interactions.
Apoptosis. 2025;30.
PubMed
Abstract available

JINDAL T, Jiang C, Alhalabi O, Nizam A, et al
Genomic Biomarkers Associated with Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma: Analysis of UNITE Study Data.
Eur Urol Oncol. 2025;8:258-262.
PubMed
Abstract available

JIANG J, Pang Y, Luo R, Wei Y, et al
Genetics of urinary bladder paragangliomas: a multi-center study of a Chinese cohort.
J Endocrinol Invest. 2025;48:931-939.
PubMed
Abstract available

BARTHELEMY P, Thibault C, Flechon A, Gross-Goupil M, et al
Real-world Study of Avelumab First-line Maintenance Treatment in Patients with Advanced Urothelial Carcinoma in France: Overall Results from the Noninterventional AVENANCE Study and Analysis of Outcomes by Second-line Treatment.
Eur Urol Oncol. 2025;8:407-416.
PubMed
Abstract available

BASILE G, Uleri A, Leni R, Cannoletta D, et al
En Bloc Versus Conventional Transurethral Resection of Bladder Tumors: A Systematic Review and Meta-analysis of Oncological, Histopathological, and Surgical Outcomes.
Eur Urol Oncol. 2025;8:520-533.
PubMed
Abstract available

BENJAMIN DJ, Kalebasty AR
Pairing the Right Individual with the Right Regimen: Patient Selection Criteria in the Treatment of Advanced Urothelial Carcinoma.
Eur Urol Oncol. 2025;8:237-238.
PubMed
Abstract available

AFFERI L, Gallioli A, Stracci D, Mattei A, et al
Lights and Shadows of Bacillus Calmette-Guerin (BCG)-exposed and BCG-unresponsive Definitions: A Practical Overview.
Eur Urol Oncol. 2025;8:231-233.
PubMed
Abstract available

COELHO KMPA, Fronza H Jr, Carvalho P, Tagliari GB, et al
Effects of the Paris System on the Unsatisfactory Category in a Cytohistologic Correlation Study of Patients With Urothelial Carcinoma.
Arch Pathol Lab Med. 2025;149:368-371.
PubMed
Abstract available

YAMAGUCHI N, Morizane S, Yamane H, Shimizu R, et al
Perioperative and Oncologic Outcomes of Robot-assisted Versus Laparoscopic Radical Cystectomy in Patients With Bladder Cancer.
Anticancer Res. 2025;45:1215-1224.
PubMed
Abstract available

ROLDAN FL, Ingelmo-Torres M, Mercader C, Figueras M, et al
Bladder EpiCheck clinical utility to predict BCG response in non-muscle-invasive bladder cancer.
BJU Int. 2025 Mar 6. doi: 10.1111/bju.16697.
PubMed
Abstract available

CHOWDHURY D, Apolo AB, Jiang DM, Skinner EC, et al
Understanding patient perspectives in the management of their muscle-invasive bladder cancer.
BJU Int. 2025 Mar 6. doi: 10.1111/bju.16695.
PubMed
Abstract available

RAUTIOLA J, Bjorklund J, Ben-David R, Skokic V, et al
Pelvic organ-sparing robot-assisted radical cystectomy in women with bladder cancer.
BJU Int. 2025 Mar 4. doi: 10.1111/bju.16691.
PubMed
Abstract available

CHEDGY ECP, Tang R, Struss WJ, Lowe G, et al
A randomized controlled trial investigating rectus sheath catheters following radical cystectomy.
BJU Int. 2023;132:554-559.
PubMed
Abstract available

COLLETT G, Bashford T, Whitehead NJ, Kazimierska E, et al
Occupational incidence of bladder cancer amongst veteran ammunition technicians of the British Army.
BJU Int. 2025 Mar 22. doi: 10.1111/bju.16678.
PubMed

TREVISANI F, Floris M, Longoni M, Rosiello G, et al
Acute kidney disease after radical cystectomy for bladder cancer: a new onco-nephrological view.
BJU Int. 2025 Mar 21. doi: 10.1111/bju.16696.
PubMed
Abstract available

YU Y, Gao X, Zhao H, Sun J, et al
A Genome-Wide Synthetic Lethal Screen Identifies Spermidine Synthase as a Target to Enhance Erdafitinib Efficacy in FGFR-Mutant Bladder Cancer.
Cancer Res. 2025 Mar 24. doi: 10.1158/0008-5472.CAN-24-3217.
PubMed
Abstract available

MONTORSI F, Rosiello G, Scilipoti P, Moschini M, et al
Re: Valeria Panebianco, Alberto Briganti, Jason Efstathiou, et al. The Role of Multiparametric Magnetic Resonance Imaging and the Vesical Imaging-Reporting and Data System (VI-RADS) in the Management of Patients with Bladder Cancer: Vision of the Amer
Eur Urol. 2025 Feb 27:S0302-2838(25)00120-4. doi: 10.1016/j.eururo.2025.
PubMed

MONTORSI F, Rosiello G, Gandaglia G, Salonia A, et al
Re: Paolo Gontero, Alison Birtle, Otakar Capoun, et al. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)-A Summary of the 2024 Guidelines Update. Eur Urol 2024;86:531-49.
Eur Urol. 2025 Mar 11:S0302-2838(25)00125-3. doi: 10.1016/j.eururo.2025.
PubMed

GONTERO P, Soria F
Reply to Francesco Montorsi, Giuseppe Rosiello, Giorgio Gandaglia, Andrea Salonia and Alberto Briganti's Letter to the Editor re: Paolo Gontero, Alison Birtle, Otakar Capoun, et al. European Association of Urology Guidelines on Non-muscle-invasive Bla
Eur Urol. 2025 Mar 11:S0302-2838(25)00140-X. doi: 10.1016/j.eururo.2025.
PubMed

FLAMMIA RS, Leonardo C, Simone G
Re: Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1).
Eur Urol. 2025 Mar 10:S0302-2838(25)00132-0. doi: 10.1016/j.eururo.2025.
PubMed

VAN DER HEIJDEN AG, Bruins HM, Carrion A, Cathomas R, et al
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines.
Eur Urol. 2025 Mar 17:S0302-2838(25)00138-1. doi: 10.1016/j.eururo.2025.
PubMed
Abstract available

VAN DOEVEREN T, Aben KKH, van Leeuwen PJ, Boormans JL, et al
Reply to Alexandra Masson-Lecomte. Bladder Cancer Recurrence Following Management of Upper Tract Urothelial Carcinoma: Balancing Prevention and Iatrogenicity. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.01.004.
Eur Urol. 2025 Mar 17:S0302-2838(25)00151-4. doi: 10.1016/j.eururo.2025.
PubMed

KOSHKIN VS, Danchaivijitr P, Bae WK, Semenov A, et al
Pembrolizumab Retreatment in Patients with Advanced or Metastatic Urothelial Carcinoma Who Responded to First-course Pembrolizumab-based Therapy.
Eur Urol. 2025;87:390-395.
PubMed
Abstract available

YU M, Goel A, Tura B, Whalley CM, et al
Towards Epigenetic-based Subtyping of Bladder Cancer: DNA Methylation Predicts Molecular Subtypes of Non-muscle-invasive Bladder Cancer.
Eur Urol. 2025 Mar 7:S0302-2838(25)00126-5. doi: 10.1016/j.eururo.2025.
PubMed

RETRACTION: Circular RNA CEP128 Promotes Bladder Cancer Progression by Regulating Mir-145-5p/Myd88 via MAPK Signaling Pathway.
Int J Cancer. 2025 Feb 28. doi: 10.1002/ijc.35391.
PubMed
Abstract available

SAZUKA T
Editorial Comment to "Differential Risk Factors for Early Intravesical Recurrence After Radical Nephroureterectomy for Upper Urinary Tract Carcinoma According to the History of Nonmuscle Invasive Bladder Cancer".
Int J Urol. 2025 Mar 3. doi: 10.1111/iju.70028.
PubMed

YAJIMA S, Hata S, Masumori N, Matsuoka Y, et al
Patient Preferences for Post-Radical Cystectomy Treatment in Muscle-Invasive Bladder Cancer: A Discrete Choice Experiment in Japan.
Int J Urol. 2025 Mar 10. doi: 10.1111/iju.70032.
PubMed
Abstract available

TAGUCHI S, Kawai T, Ambe Y, Kishitani K, et al
Physical, but not laboratory, treatment-related adverse events are associated with favorable outcomes of enfortumab vedotin for advanced urothelial carcinoma: A landmark analysis.
Int J Urol. 2025;32:270-276.
PubMed
Abstract available

SANO T, Ohe C, Nakamoto T, Yoshida T, et al
Pathological Analysis of False-Positive Samples in Photodynamic Diagnosis of Bladder Cancer According to a History of Intravesical Bacillus Calmette-Guerin Therapy.
Int J Urol. 2025 Mar 26. doi: 10.1111/iju.70045.
PubMed
Abstract available

WU YJ, Chang SJ, Huang YS, Chai CY, et al
Overexpression of BMAL-1 is related to progression of urothelial carcinoma in arsenic exposure area.
Int Urol Nephrol. 2025;57:1175-1187.
PubMed
Abstract available

TALLMAN JE, Vertosick EA, Alam SM, Baky FJ, et al
Perioperative Complications and Omission of Ureteral Stents During Robot-Assisted Radical Cystectomy With Intracorporeal Ileal Conduit.
J Urol. 2025;213:437-446.
PubMed
Abstract available

AHMED ME, Andrews JR, Mahmoud AM, Reitano G, et al
Intraoperative Tranexamic Acid in Radical Cystectomy: Impact on Bleeding, Thromboembolism, and Survival Outcomes.
J Urol. 2025;213:447-454.
PubMed
Abstract available

STOVER AM, Mueller D, Carda-Auten J, Hilton A, et al
Perceived Impact on Patient Routines/Responsibilities for Surgery and a Nonsurgical Primary Treatment Option in Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer: Findings From the ENVISION Phase 3 Trial.
J Urol. 2025 Mar 6:101097JU0000000000004511. doi: 10.1097/JU.0000000000004511.
PubMed
Abstract available

KAMAT AM, van Rhijn BWG, Van der Kwast T
Hybrid 3-Tier Bladder Cancer Grade: The Mutually Beneficial Marriage Of Two Grading Systems.
J Urol. 2025 Mar 25:101097JU0000000000004542. doi: 10.1097/JU.0000000000004542.
PubMed

PYRGIDIS N, Volz Y, Takayama Fouladgar S, Ebner B, et al
The role of radical cystectomy with orthotopic neobladder reconstruction in patients developing bladder cancer after prior radical prostatectomy, radiation therapy or BPH surgery.
Urol Int. 2025 Mar 6:1-17. doi: 10.1159/000545103.
PubMed
Abstract available

LONGONI M, Penaranda NR, Marmiroli A, Falkenbach F, et al
Survival outcomes and temporal trends of non-surgical management versus radical cystectomy in non-organ-confined urothelial bladder cancer.
Urology. 2025 Mar 6:S0090-4295(25)00216-X. doi: 10.1016/j.urology.2025.
PubMed
Abstract available

CETIN T, Bolat D, Akgul M, Yazici S, et al
Effect of Bacillus Calmette-Guerin Instillation Timing on Oncological Survivals After Transurethral Resection of Bladder Tumor.
Urology. 2025;197:126-132.
PubMed
Abstract available

YEGUEZ AC, Talwar R, Smith AL
Optimizing Care for Women through Gynecologic Organ Considerations During Cystectomy: A Pre-Operative Checklist of Important Considerations.
Urology. 2024 Nov 28:S0090-4295(24)01095-1. doi: 10.1016/j.urology.2024.
PubMed
Abstract available

WILLIAMS SB, Yapici HO, Singhal PK, Weimer I, et al
Real-World Economic Burden and Healthcare Resource Utilization of Radical Cystectomy and Trimodal Therapy for Bladder Cancer in the United States.
Urology. 2025 Mar 21:S0090-4295(25)00280-8. doi: 10.1016/j.urology.2025.
PubMed
Abstract available

MALSHY K, Bandari J, Cheng Z, Kadambi S, et al
Tailoring Cystoscopy Surveillance: Addressing the Needs of Frail Bladder Cancer Patients.
Urology. 2025 Mar 21:S0090-4295(25)00253-5. doi: 10.1016/j.urology.2025.
PubMed

SADE JP, Ferraris F, Raman J
The (Re) evolution in the treatment of bladder cancer.
Urology. 2025 Mar 21:S0090-4295(25)00287-0. doi: 10.1016/j.urology.2025.
PubMed

SHENG Z, Xu J, Wang M, Xu X, et al
The role of urinary microbiota in primary and recurrent bladder cancer: insights from a propensity score matching study.
BMC Cancer. 2025;25:468.
PubMed
Abstract available

YANG H, Zhang T, Li Z, Cai Y, et al
Risk factors for in-hospital venous thromboembolism in patients with bladder cancer: A retrospective single-center study.
BMC Cancer. 2025;25:536.
PubMed
Abstract available

WAN S, Li KP, Chen SY, Wang CY, et al
Single-cell sequencing combined with urinary multi-omics analysis reveals that the non-invasive biomarker PRDX5 regulates bladder cancer progression through ferroptosis signaling.
BMC Cancer. 2025;25:533.
PubMed
Abstract available

DAI L, Ye K, Yao G, Lin J, et al
Using machine learning for predicting cancer-specific mortality in bladder cancer patients undergoing radical cystectomy: a SEER-based study.
BMC Cancer. 2025;25:523.
PubMed
Abstract available

KONDO Y, Mihara T, Yoshikawa N, Echigo N, et al
Preoperative antihypertensives and hypotension during bladder tumor resection with oral 5-aminolevulinic acid administration.
PLoS One. 2025;20:e0319413.
PubMed
Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.

;